BDMD

Baird Medical Investment Holdings Ltd Ordinary Share

7.09 USD
-0.19
2.61%
At close Jan 31, 4:00 PM EST
After hours
7.00
-0.09
1.27%
1 day
-2.61%
5 days
0.85%
1 month
-6.71%
3 months
160.66%
6 months
18.17%
Year to date
38.48%
1 year
18.17%
5 years
18.17%
10 years
18.17%
 

About: Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Funds holding %
of 6,831 funds
Analysts bullish %

Fund manager confidence

Research analyst outlook

We haven’t received any recent analyst ratings for BDMD.

Financial journalist opinion

Based on 9 articles about BDMD published over the past 30 days

Neutral
PRNewsWire
1 day ago
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations
NEW YORK , Jan. 30, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, today announced its successful participation in the 2025 Microcap Conference, held at the Borgata Hotel in Atlantic City, New Jersey.
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations
Neutral
PRNewsWire
4 days ago
Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology
NEW YORK , Jan. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, reflects on a landmark year of innovation and achievement.
Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology
Neutral
PRNewsWire
1 week ago
Baird Medical to Participate in NASIT 2025 Conference
NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 2025 North American Society for Interventional Thyroidology (NASIT) Conference, taking place January 31 – February 1, 2025, in Washington, D.C.
Baird Medical to Participate in NASIT 2025 Conference
Neutral
PRNewsWire
1 week ago
Baird Medical to Attend Microcap Conference at Borgata Hotel
NEW YORK , Jan. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation technology (MWA), announced today that it will participate in the highly anticipated Microcap Conference, set to take place at the Borgata Hotel in Atlantic City, New Jersey, from January 28 to January 30, 2025.
Baird Medical to Attend Microcap Conference at Borgata Hotel
Neutral
PRNewsWire
1 week ago
Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
NEW YORK , Jan. 22, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is expanding its presence into San Francisco, marking an important step in its U.S. growth strategy.
Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
Neutral
PRNewsWire
1 week ago
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
NEW YORK , Jan. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, proudly announces that Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, has reached a remarkable milestone of successfully completing 100 MWA procedures for thyroid nodules.
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
Neutral
PRNewsWire
2 weeks ago
Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference
NEW YORK , Jan. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, was present in San Francisco amid the 2025 J.P.
Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference
Neutral
PRNewsWire
2 weeks ago
Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment
NEW YORK , Jan. 13, 2025 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. This program offered physicians practical experience with a state-of-the-art treatment designed to deliver quicker recovery and effective management of thyroid nodules.
Baird-Sponsored Microwave Ablation Training Advances Thyroid Treatment
Neutral
PRNewsWire
3 weeks ago
Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference
NEW YORK , Jan. 6, 2025 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, successfully sponsored and participated in the 4th Sichuan Medical Association Thyroid Disease Academic Conference, held in Sichuan, China. The highly regarded conference gathered top thyroid specialists and healthcare professionals to promote best practices in thyroid disease diagnosis and treatment.
Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference
Neutral
PRNewsWire
1 month ago
Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
NEW YORK , Dec. 30, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leading innovator in minimally invasive microwave ablation (MWA) technology, proudly supported and participated in the 2024 Guangdong Provincial Parathyroid Disease - Southern Yue Forum, held in Guangzhou, China. This distinguished forum, organized by prominent healthcare institutions in Guangdong, brought together esteemed medical experts, researchers, and healthcare professionals to share insights on advancements in the diagnosis and treatment of parathyroid diseases.
Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
Charts implemented using Lightweight Charts™